The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.

Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation ...

The FBI has released a new image of Ryan James Wedding, the Canadian ex-Olympian allegedly behind a deadly international drug ...

ACE1831 is an allogeneic gamma delta T cell therapy candidate targeting CD20-expressing cells currently being investigated in non-Hodgkin's lymphoma (NHL) The planned clinical study will be executed ...

PharmaTher Holdings Ltd. (the "Company” or "PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the Company requested a post-complete letter clarification ...

This study introduces a novel lignin-based hydrogel with controlled release and enhanced mechanical strength, leveraging ...

The US FDA has cleared an investigational new drug (IND) application for HG202, by HuidaGene Therapeutics. This drug is the ...

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

The FDA previously granted donidalorsen Orphan Drug Designation ... Application (MAA) to the European Medicines Agency (EMA) this year. Ionis recently presented new results from the Phase ...